Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
TAF + Emtricitabine + Rilpivirine bulk supplier for pharma manufacturers

Taf + Emtricitabine + Rilpivirine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: (TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg

Reference Brands: Odefsey(US & EU)

Category: Anti Viral

Odefsey is a once-daily HIV-1 treatment combining TAF, Emtricitabine, and Rilpivirine. FDA and EMA approved, it offers improved kidney and bone safety compared to TDF-based regimens and must be taken with food.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Odefsey is a once-daily, fixed-dose combination tablet containing Tenofovir Alafenamide (TAF) 25 mg, Emtricitabine 200 mg, and Rilpivirine 25 mg, used for the treatment of HIV-1 infection in virologically suppressed patients or treatment-naïve individuals without resistance to its components. Approved by the FDA and EMA, Odefsey is a TAF-based alternative to older TDF regimens like Complera/Eviplera, offering improved renal and bone safety. It is indicated for adults and adolescents (≥12 years and ≥35 kg) and must be taken with a meal. Odefsey simplifies therapy by combining three potent agents into a single-tablet regimen.

Taf + Emtricitabine + Rilpivirine — third party manufacturing & bulk supply

Taf + Emtricitabine + Rilpivirine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Taf + Emtricitabine + Rilpivirine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Taf + Emtricitabine + Rilpivirine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Taf + Emtricitabine + Rilpivirine →
Back to Listing

Frequently Asked Questions

Tenofovir alafenamide + emtricitabine + rilpivirine is used for the treatment of HIV-1 infection in adults who are virologically suppressed. It helps maintain viral suppression and supports long-term HIV management as a complete once-daily regimen.

It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, and rilpivirine. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, while rilpivirine is a non-nucleoside reverse transcriptase inhibitor.

The main trade name is Odefsey in the USA, EU, and UK.

Odefsey is manufactured by Gilead Sciences in collaboration with Janssen.

The generic name is tenofovir alafenamide + emtricitabine + rilpivirine.

The primary brand name is Odefsey.

It is manufactured by Gilead Sciences in the USA and EU, along with authorized global production partners.

Related Products

Taf + Emtricitabine + Elvitegravir + Cobicistat

Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg

Form: Tablet

Reference Brands: Genvoya(US & EU)

View Details
Tenofovir Af + Emtricitabine + Bictegravir

Strength:
Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg

Form: Tablet

Reference Brands: Biktarvy(EU & US)

View Details
Tenofovir Af + Emtricitabine

Strength:
Tenofovir AF 25 mg + Emtricitabine 200 mg

Form: Tablet

Reference Brands: Descovy(EU & US)

View Details
Taf + Emtricitabine + Darunavir + Cobicistat

Strength:
Darunavir- 800 mg + Cobicistat-1 50 mg + Emtricitabine- 200 mg + TAF-10 mg

Form: Tablet

Reference Brands: Symtuza(Eu & US)

View Details
Efavirenz

Strength:
Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg

Form: Tablet & Capsule

Reference Brands: Sustiva®(US); Stocrin®(EU)

View Details
Efavirenz + Emtricitabine + Tdf

Strength:
600/200/300 mg

Form: Tablet

Reference Brands: Atripla(US/EU)

View Details
Lamivudine & Zidovudine

Strength:
Lamivudine 150 mg + Zidovudine 300 mg

Form: Tablet

Reference Brands: Combivir®(US/ EU)

View Details
Lamivudine

Strength:
Tab:150 mg, 300 mg; Oral solution:10 mg/mL

Form: Tablet & Oral solution

Reference Brands: Epivir®(US/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.